Jesus Duque-Afonso

Has grant

faculty of medicine university of freiburg freiburg germany

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Mechanisms of resistance to targeted therapy and chemotherapy in acute lymphoblastic leukemias

Open Date: 2019-10-01

Close Date: 2022-09-01

Grant: Close

Genomics-based tools for personalized treatment to reduce chemotherapy burden in pediatric cancer (GEPARD)

Open Date: 2019-07-01

Close Date: 2022-06-01

Grant: Close

Identification of mechanisms of resistance to targeted therapy and chemotherapy in acute lymphoblastic leukemia

Open Date: 2019-04-01

Close Date: 2020-10-01

Grant: Close

Non-invasive monitoring of minimal residual disease and Graft-versus-Host Disease by circulating nucleic acids after allogeneic hematopoietic transplantation

Open Date: 2019-01-01

Close Date: 2020-12-01

Grant: Close

Functional characterization of the TGFβ signalling pathway in acute lymphoblastic leukemia

Open Date: 2017-01-01

Close Date: 2017-12-01

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (13)

Martin Boeker

´Professor for Medical Informatics

Technical University of Munich (TUM)

GERMANY

View details

Charles Craddock

University of Birmingham

UNITED KINGDOM

View details

Dieter Henrik Heiland

University of Freiburg

GERMANY

View details

Patrick Metzger

GERMANY

View details

Frank Meiss

University Medical Center Freiburg

GERMANY

View details

Claudia Wehr

GERMANY

View details

Robert Zeiser

Director Div. of Tumor immunology/Professor

University Medical Center Freiburg

GERMANY

View details

Thalia Erbes

University of Freiburg

GERMANY

View details

Andreas Tzschach

University Medical Center Freiburg

GERMANY

View details

Gregor Reid

Associate Professor

The University of British Columbia

CANADA

View details

Philipp Poxleitner

University Medical Center Freiburg

GERMANY

View details

Simone Hettmer

University Medical Center Freiburg

GERMANY

View details

Ralph Wäsch

faculty of medicine university of freiburg freiburg germany

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jesus Duque-Afonso

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (20)

Influence of daytime of allogeneic stem cell transplantation on incidence of acute graft vs. host disease: a retrospective analytical cohort study

Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party

Reduced Intensity Conditioning Prior Autologous Stem Cell Transplantation in Elderly DLBCL Patients

Long‐term complete remissions of refractory severe idiopathic immune thrombocytopenia treated with daratumumab: A case series

Identification of epigenetic modifiers essential for growth and survival of AML1/ETO‐positive leukemia

Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party

Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens

Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR+ Acute Lymphoblastic Leukemia

Age and ligand specificity influence the outcome of pathogen engagement on preleukemic and leukemic B-cell precursor populations

Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure

Progenitor-like cell type of an MLL-EDC4 fusion in acute myeloid leukemia

Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party

Monitoring of Measurable Residual Disease Using Circulating DNA after Allogeneic Hematopoietic Cell Transplantation

The epigenetics of breast cancer – Opportunities for diagnostics, risk stratification and therapy

Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis

The impact of pulmonary function in patients undergoing autologous stem cell transplantation

AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms

Correction to: Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia

Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia

Comparison of reduced-toxicity conditioning protocols using fludarabine, melphalan combined with thiotepa or carmustine in allogeneic hematopoietic cell transplantation

Collaborators (13)

Martin Boeker

Charles Craddock

Dieter Henrik Heiland

Patrick Metzger

Frank Meiss

Claudia Wehr

Robert Zeiser

Thalia Erbes

Andreas Tzschach

Gregor Reid

Philipp Poxleitner

Simone Hettmer

Ralph Wäsch

Make your next move.